Nihms 1020044
Nihms 1020044
Nihms 1020044
Author manuscript
J Dairy Sci. Author manuscript; available in PMC 2019 April 02.
Author Manuscript
2Institute of Life Science, Swansea University Medical School, Swansea, SA2 8PP, United
Kingdom
Abstract
Bacterial infection of the uterus causes clinical endometritis in 15 to 20% of postpartum dairy
cows and reduces fertility, even after the resolution of disease. However, it is difficult to
disentangle the mechanisms linking reduced fertility with endometritis because cows have
multiple confounding postpartum conditions. The aim of the present experiment was to develop an
in vivo model of clinical endometritis in Holstein heifers using pathogenic Escherichia coli and
Trueperella pyogenes. Estrous cycles of heifers were synchronized using a 5-d Co-Synch protocol,
and subsequently received exogenous progesterone to elevate circulating progesterone at the time
of uterine infusion. Endometrial scarification was performed before uterine infusion of live
Author Manuscript
pathogenic Escherichia coli and Trueperella pyogenes, or sterile vehicle. Effects of infusion were
evaluated by measuring rectal temperature, plasma haptoglobin, hematology, grading pus in the
vaginal mucus, quantifying 16S rRNA in vaginal mucus, and transrectal ultrasonography. Bacterial
infusion increased the median vaginal mucus to grade 2 by d 3 postinfusion, and to grade 3 from d
4 to 6 postinfusion. Control heifers maintained a median vaginal mucus grade ≤1 from d 1 to 6.
Transrectal ultrasound revealed the accumulation of echogenic fluid in the uterus of heifers
following bacterial infusion, which was absent in control heifers. Total 16S rRNA in vaginal
mucus was elevated in bacteria-infused heifers compared with control heifers at d 5. Rectal
temperature was increased in bacteria-infused heifers. Plasma haptoglobin, general health, and
appetite did not differ between groups. As indicated by increased vaginal mucus grade after
bacterial infusion and absence of systemic signs of illness, this model successfully induced
symptoms resembling clinical endometritis in virgin Holstein heifers. The model allows the
Author Manuscript
isolation of effects of uterine disease on fertility from confounding factors that can occur during
the postpartum period in dairy cows.
Keywords
animal model; dairy cow; clinical endometritis; inflammation; uterine infection
*
Corresponding author: jbromfield@ufl.edu.
Piersanti et al. Page 2
INTRODUCTION
Author Manuscript
Cows with clinical endometritis do not have systemic signs of disease, and diagnosis is
based on the presence of a purulent uterine discharge detectable in the vagina 21 d or more
postpartum (LeBlanc et al., 2002; Sheldon et al., 2006). The vaginal contents can be
examined using a gloved hand, a Metricheck tool (Simcro, Hamilton, New Zealand), or a
speculum, and the severity of clinical endometritis can be graded by the amount of pus in the
mucus. There is debate about whether purulent vaginal discharge may also reflect cervicitis
or vaginitis because not all cows with purulent vaginal discharge have infiltration of
polymorphonuclear neutrophils detectable by endometrial cytology (Dubuc et al., 2010).
Nevertheless, bacteria can be isolated from the uterus of cows with endometritis, and the
presence of pus in the uterus or a slightly enlarged uterus can also be visualized using
transrectal ultrasonography (Sheldon et al., 2002).
Author Manuscript
pyolysin is greatest in the stroma, which is exposed when the epithelium is lost during the
peripartum period (Sheldon et al., 2010; Amos et al., 2014). Furthermore, peripartum
problems that traumatize the endometrium, such as dystocia and retained fetal membranes,
increase the risk of development of endometritis (Dubuc et al., 2010; Potter et al., 2010;
Ribeiro et al., 2013).
Uterine disease is associated with prolonged luteal phases, slowed rate of growth of ovarian
follicles post-partum, and impaired ovarian endocrine function (Opsomer et al., 2000;
Sheldon et al., 2002). However, the mechanisms linking endometritis with reproduction are
Author Manuscript
not fully established because fertility is also perturbed by many of the risk factors for
endometritis, including peripartum problems and the inability to adapt to the shifts in
metabolism to accommodate lactation (Chagas et al., 2007; LeBlanc, 2012). Animal models
of clinical endometritis have been reported using mature cows infused with T. pyogenes
(Rowson et al., 1953; Ayliffe and Noakes, 1982; Farin et al., 1989; Amos et al., 2014).
However, an experimental model of endometritis in heifers would be attractive for exploring
how uterine infection affects reproduction. Using heifers as the basis for the model
circumvents many of the confounding effects of parturition and lactation observed in
lactating cows. The aim of the present experiment was to develop a defined in vivo infection
model of clinical endometritis in Holstein heifers using pathogenic E. coli and T. pyogenes.
The University of Florida Institutional Animal Care and Use Committee approved all
procedures with heifers under protocol number 201508884. The experiment was conducted
from June to October 2017 at the University of Florida Dairy Unit.
The experiment followed a randomized complete block design with heifer as the
experimental unit. Heifers were blocked by age and weight, and randomly assigned to 1 of 2
infusion treatments: intrauterine infusion of sterile vehicle medium alone (n = 5) or
intrauterine infusion of live bacteria (n = 4; details below).
Estrous cycles were synchronized using a modified 5-d Co-synch protocol (Lima et al.,
2013). Briefly, heifers received 100 mg i.m. of GnRH (gonadorelin diacetate tetrahydrate;
Ovacyst, Bayer) followed by 25 mg i.m. of PGF2α (dinoprost tromethamine; Prostamate,
Bayer) administered 5 and 6 d later (Figure 1A). Eight days following initial GnRH, heifers
received a final dose of 100 mg of GnRH i.m. Starting on the day following the final GnRH,
Author Manuscript
heifers received 200 mg i.m. of progesterone (P4) in corn oil (50 mg/mL; Sigma-Aldrich, St
Louis MO) daily for 7 d. Exogenous P4 was administered to mimic diestrus and ensure
elevated circulating P4 at the time of bacterial infusion.
(Aspen Veterinary Resources, Greeley, CO). The perineum and vulva were cleaned and
Author Manuscript
disinfected with povidone iodine followed by 70% ethanol, and a sterile metal scarification
tool enclosed by a metal catheter covered in a sanitary sheath (IMV Technologies,
Normandy, France) was introduced through the vagina and cervix. The scarification tool
consisted of a stainless-steel rod with a 39-mm-long, 6-mm-diameter threaded component
on the tip, similar to a threaded bolt (Figure 1B). The scarification tool was manipulated
through the cervix and into the body of the uterus by transrectal palpation. Once inside the
body of the uterus, the sanitary sheath was retracted, and the scarification tool was placed in
direct contact with the endometrium. The scarification tool was then rotated once to disrupt
the endometrial lining before removal from the reproductive tract. Inspection of the
scarification tool upon retraction confirmed tissue disruption by the presence of small pieces
of tissue. Following endometrial scarification, a metal infusion catheter enclosed in a
sanitary sheath was introduced transcervically into the body of the uterus. The sanitary
Author Manuscript
sheath was retracted, and treatments were infused using 10-mL syringes. Bacterial infusion
consisted of 10 mL of 4.64 × 107 cfu/mL of E. coli MS499, 10 mL of 3.38 × 107 cfu/mL T.
pyogenes MS249 followed by 10 mL of sterile Luria-Bertani (LB) broth to flush the catheter
(Goldstone et al., 2014a,b). Vehicle infusion consisted of 30 mL of LB broth. Heifers were
returned to pasture and monitored for clinical signs for 24 h.
Animals did not receive any additional treatments or medication during the experimental
period.
Escherichia coli was cultured from frozen glycerol stocks on LB agar. The day before
infusion, a single colony was picked from the plate and inoculated into LB broth containing
1% tryptone, 0.5% yeast extract, and 1% sodium chloride. The culture was incubated
overnight at 37°C with shaking at 200 rpm. Growth was monitored by measuring optical
density at 600 nm (OD600 = 5.0). A final preparation of 4.64 × 107 cfu/mL E. coli was
diluted in sterile LB broth and loaded into 10-mL syringes for infusion.
Trueperella pyogenes MS249 was grown from frozen glycerol stocks on Trypticase Soy
Blood agar at 37°C for 48 h. The day before infusion, a single colony was selected and
inoculated into Bacto Brain Heart Infusion broth (BHI, Fisher Scientific, Pittsburgh, PA)
supplemented with 5% fetal bovine serum (FBS, Fisher Scientific) and cultured overnight at
37°C with shaking at 200 rpm. Growth was monitored by measuring optical density at 600
Author Manuscript
nm (OD600 = 0.2). A final preparation of 3.38 × 107 cfu/mL T. pyogenes was diluted in
sterile BHI and loaded into 10-mL syringes for infusion. Syringes were loaded with sterile
LB broth for flushing catheters and vehicle infusions. Inoculants were transported to the
farm on ice for infusion.
Blood was collected from the coccygeal vessels into evacuated tubes (Vacutainer, Becton
Dickson, Franklin Lakes, NJ) containing sodium heparin for plasma separation or potassium
EDTA for hematology. Blood was sampled every other day from d −2 to 18 relative to
treatment. Blood was placed on ice until further processing. Tubes containing heparin were
centrifuged and plasma was collected, aliquoted, and stored at −20°C. Whole blood was
transported to the laboratory on ice within 2 h of collection and used for hematology
analysis performed using an automated hematology analyzer (ProCyte Dx Hematology
Analyzer, IDEXX Laboratories, Westbrook ME). Hematology analysis included total and
differential leukocyte counts (neutrophils, lymphocytes, and eosinophils), red blood cells,
hematocrit, and hemoglobin. Hematology was evaluated on d −1, 1, 3, and 7 relative to
treatment (Figure 1A).
Author Manuscript
Plasma haptoglobin (Life Diagnostics Inc., West Chester, PA) and P4 (DRG International
Inc., Spring-field, NJ) were measured using commercially available ELISA according to the
manufacturer’s instructions. Plasma haptoglobin was evaluated on d 0, 7, and 13 relative to
treatment, and P4 was evaluated on d −2, 1, 4, 11, and 17 relative to treatment (Figure 1A).
The P4 ELISA is human specific and was validated for bovine plasma using spike-in/
recovery performance based on actual and expected recovery of P4 supplied as standard with
the kit. The intraassay coefficient of variation was calculated at 6.5%, and recovery of spike-
in P4 was 89 to 101.8% of expected P4.
mucus was scored as grade 0, no mucus or clear or translucent mucus; grade 1, mucus
containing flecks of white or off-white pus; grade 2, mucus containing ≤50% white or off-
white mucopurulent material; and grade 3, mucus containing >50% purulent material
(Sheldon et al., 2009). Evaluation of vaginal mucus was performed daily from d −1 to 7
relative to treatment (Figures 2A–2C).
Transrectal ultrasonography with a linear 5.0 MHz probe (Aloka SSD-500, Hitachi
Healthcare Americas, Twinsburg, OH) was performed to visualize fluid and pus in the
uterus. Ultrasonography was performed every other day from d −1 to 10 relative to
treatment. Rectal temperature (AG-102 thermometer, AG-Medix, Mukwonago, WI) was
measured daily between 0700 and 0900 h from d −11 to 10 relative to treatment. A rectal
temperature of >39.5°C was classified as fever.
Author Manuscript
with garnet particles using 3 bead beater cycles (30 s at 6,000 × g, 60 s pause, 30 s at 6,000
Author Manuscript
Total 16S rRNA was quantified using the Femto Bacterial DNA Quantification Kit
according to the manufacturer’s instructions (Zymo Research, Irvine, CA). Thermocycling
conditions included initial denaturation at 95°C for 10 min, 40 cycles of amplification
consisting of denaturation at 95°C for 30 s, annealing at 50°C for 30 s and extension at 72°C
for 1 min, followed by a final extension at 72°C for 7 min. A total of 2 μL of extracted total
DNA sample was applied to each PCR reaction. Quantification of 16S rRNA was analyzed
based on a standard curve performed in parallel with mucus samples. Data for total 16S
rRNA are described as nanograms of 16S rRNA per milligram of vaginal mucus. The
extraction of 16S rRNA in mucus samples was validated using spike-in/recovery using
known quantities of purified bacteria. Intraassay coefficient of variation was calculated at
Author Manuscript
0.3%, interassay coefficient of variation was calculated at 2.2%, and recovery of 16S rRNA
following extraction of bacteria spike-in pus was 100.5% of expected 16S rRNA content.
Statistical Analysis
All data were analyzed using SAS v. 9.4 (SAS Institute Inc., Cary, NC). Vaginal mucus
grade was reported as the median for each treatment group and analyzed using the
GLIMMIX procedure following a Poisson distribution. Cow within treatment was
considered a random effect, and fixed effects of treatment and day were analyzed.
Haptoglobin, P4, hematology, and DNA concentration for the 16S rRNA gene were
analyzed using the MIXED procedure of SAS and the models included the fixed effects of
treatment (bacterial infusion), day (repeated measure), and their interaction. Heifer nested
within treatment was considered as a random effect. First order autoregressive covariance
Author Manuscript
structure AR (1) was used as the covariate structure. Values are reported as least squares
means ± standard error of the mean. Differences with P ≤ 0.05 were considered statistically
significant.
RESULTS
Intrauterine Bacterial Infusion Increased Vaginal Mucus Grade
Vaginal discharge of pus was visually evident in heifers that were infused with live bacteria,
but not in control heifers (Figure 2A). Vaginal mucus collected by Metricheck was graded
and compared between treatments (Figure 2B–2C). An increase (P < 0.02) was observed in
the vaginal mucus grade of heifers treated with bacteria (Figure 3). Heifers in both infusion
groups had a median mucus grade of 0 before uterine infusion (Figure 3). Intrauterine
Author Manuscript
Total vaginal 16S rRNA was increased (P < 0.05) in bacteria-infused heifers compared with
control heifers on d 5 (Figure 4A). In addition, total vaginal 16S rRNA was greater (P <
0.05) on d 5 in heifers infused with bacteria compared with other sampled days (Figure 4A).
No interaction was observed between treatment and day relative to treatment (P = 0.14).
relative to treatment (40.0 and 40.2°C). No overt signs of systemic disease were observed in
any heifers.
concentrations of P4 in plasma (P > 0.05, Figure 4C). The peak concentration was observed
on d 4 relative to treatment, and once exogenous P4 supplementation was concluded on d 4,
concentrations decreased in both treatments.
DISCUSSION
The present experiment developed an in vivo model of clinical endometritis in Holstein
heifers using pathogenic E. coli and T. pyogenes. Heifers that received intrauterine infusion
of pathogenic bacteria developed purulent vaginal mucus, accumulation of echogenic fluid
in the uterus, and increased bacterial load in vaginal mucus. In parallel, bacteria-infused
heifers displayed no systemic signs of illness, such as altered hematology or general
sickness. Control heifers did not display any of the clinical signs of clinical endometritis.
Based on the criteria previously described for the disease, these results recapitulate the
Author Manuscript
symptoms of clinical endometritis observed in the postpartum dairy cow (LeBlanc et al.,
2002; Sheldon et al., 2006, 2009).
Previous experimental models of clinical endometritis have focused on the use of mature
cows and intrauterine infusion of T. pyogenes (Rowson et al., 1953; Ayliffe and Noakes,
1982; Amos et al., 2014). These studies were capable of generating active infection of the
uterus, evident by the presence of mucopurulent vaginal contents, using a single uterine
pathogen. Although these models induce clinical symptoms of disease, it may be that the use
Author Manuscript
of a second pathogen, E. coli, better reflects the molecular profile of endometritis to evaluate
the consequences of disease on fertility. The dual pathogen model of Del Vecchio et al.
(1992) used repeated infusions of both E. coli and T. pyogenes over the course of 3 d (Del
Vecchio et al., 1992); however, the strain and pathogenicity of bacteria used may also be
important. Strains used by others include β-hemolytic E. coli or T. pyogenes sourced from
cows with severe endometritis (presumably from the uterus). Additionally, Farin et al.
(1989) used intrauterine infusion of T. pyogenes and the gram-negative anaerobes,
Fusobacterium necrophorum and Bacteroides melaninogenicus (now Prevotella
melaninogenica), to induce “pyometria” in lactating multiparous cows. The model describes
the implementation of tissue damage using an intrauterine infusion of iodine solution, and
intravenous administration of hCG to ensure elevated circulating P4, 2 factors recapitulated
in our model but using different approaches. The model of Farin et al. (1989) also reports the
Author Manuscript
consistent isolation and culture of uterine T. pyogenes during an extended window of active
disease lasting up to 30 d postinfusion in some cows. The presence of E. coli was not
reported in these studies, and isolation and culture of the anaerobes, F. necrophorum and P.
melaninogenica, were inconsistent between cows with disease (Farin et al., 1989).
Pathogenic strains of E. coli and T. pyogenes used in the current model were sourced from
the uterus of cows with endometritis and have subsequently been sequenced (Goldstone et
al., 2014a,b), allowing a detailed understanding of virulence factors and host-pathogen
interactions involved in disease. These 2 species of pathogens were specifically chosen to
establish infection as they are readily detectable within days of parturition in the uterus of
cows that develop spontaneous uterine disease (Dohmen et al., 2000; Bicalho et al., 2012).
The pore-forming toxin produced by T. pyogenes causes cellular damage to the
endometrium during active infection, although little is known about its actions on ovarian
function, especially after the clearance of disease. Conversely, LPS derived from gram-
Author Manuscript
negative bacteria is present in follicular fluid after the resolution of uterine disease. Indeed,
studies have demonstrated that the presence of LPS negatively effects oocyte development
and alters the follicular environment of the growing oocyte in vitro (Bromfield and Sheldon,
2011).
Species other than the cow have been used to develop models of uterine infection, including
the sheep and mouse (Regassa et al., 2002; Sheldon and Roberts, 2010; Bromfield and
Sheldon, 2013). However, when attempting to determine the mechanisms by which
endometritis affects fertility of the dairy cow, it is imperative to use the target species in
question. Rodents are relatively inexpensive and convenient for such a model, but the
reproductive physiology and immune function of the mouse is considerably different from
those of the cow. Mice have been shown to be 1 million-fold less sensitive to LPS than
Author Manuscript
humans (Seok et al., 2013). More appropriately, the human and bovine genomes share a high
degree of AA sequence homology, limited species-specific orthologs, and a similar
chromosomal organization, suggesting the bovine as a useful experimental model for human
physiology (The Bovine Genome Sequencing and Analysis Consortium et al., 2009). In
addition, bovine reproductive biology is closer to that of humans than mice; cows and
humans are both monotocous with similar hormonal profiles over a 3- to 4-wk ovarian cycle,
compared with the polytocous mouse with a 4-d estrous cycle. The current model of
endometritis may even serve as a tool to study the effects of uterine infections on human
Author Manuscript
fertility.
The use of the Holstein heifers in the present experiment was a deliberate choice in the
generation of the experimental model presented. The long-term goal of this model is to study
the mechanisms of endometritis-mediated reproductive failure in the cow. As uterine disease
occurs in the early postpartum period, several significant challenges can confound
experimental investigation into the causes of endometritis-mediated infertility. Specifically,
postpartum uterine damage, uterine involution, metabolic demands of lactation, negative
nutrient balance, and additional postpartum illnesses that affect almost half of all postpartum
cows (Ribeiro et al., 2016). Retained placenta and dystocia are significant risk factors for the
development of endometritis, and are both associated with damage to the endometrium
(Dubuc et al., 2010). To recapitulate postpartum endometrial damage, we performed a
scarification procedure to disrupt the endometrial epithelial layer at the time of bacterial
Author Manuscript
infusion. This process of scarification may be critical to the establishment of the disease
model to facilitate bacterial access to the underlying stroma. Previous work has reported
differential susceptibility of epithelial and stromal endometrial cells to pathogenic E. coli,
with pathogenic E. coli binding with stronger affinity to stromal cells, and purified LPS
inducing a stronger inflammatory reaction in the endometrial stroma (Sheldon et al., 2010).
A similar phenomenon of differential cellular susceptibility has been described in the
response of endometrial epithelial and stromal cells to T. pyogenes pyolysin, in which
stroma cells are considerably more sensitive to the cytoxic effects of pyolysin (Amos et al.,
2014), suggesting the stroma is the target of pyolysin. These in vitro experiments, in
combination with the risk factors associated with endometritis, suggest that endometrial
scarification may be an important procedure in the establishment of clinical endometritis
observed in the present model.
Author Manuscript
Hansen, 1998; Seals et al., 2002; Lewis, 2003). The ability of steroid hormones to modulate
endometrial immune function have led to the practice of administering PGF2α as a treatment
for uterine infection to induce luteolysis in cows in diestrus, and elevate estrogen by
stimulating a new follicular phase of the estrous cycle (Lewis, 1997); however, this remains
debated. In parallel, 55% of cows with metritis display extended luteal phases (Etherington
et al., 1991; Opsomer et al., 2000). The extension of the luteal phase in cows with uterine
disease can have consequences on the calving to conception interval, negatively affecting
productivity. Exposure of endometrial cells to bacterial LPS in vitro switches prostaglandin
synthesis from luteolytic PGF2α to luteotrophic PGE2 (Herath et al., 2006, 2009). This
Author Manuscript
could have inoculated the cervix and vagina. However, quantification of vaginal 16S rRNA
the day after infusion on experiment d 1 revealed comparable total bacterial load between
treatments. The presence of elevated 16S rRNA observed in the bacteria-infused heifers 5 d
following infusion suggests that mucopurulent vaginal discharge is derived from the infected
uterus induced by infused bacteria, and not from environmental contamination. The
accumulation of echogenic uterine fluid in bacteria-infused heifers supports these
assumptions and suggests that any cervicitis or vaginitis would likely be the result of
contamination or excessive manipulation, and would also be observed in vehicle-infused
controls. Interestingly, however, hematological evaluation of heifers suggests a possible
effect of the procedure of infusing material into the uterus itself. Although we did not
observe a treatment effect for any of the hematological parameters evaluated, we did see an
effect of day on numbers of red blood cells, lymphocytes, and platelets, and the percent of
Author Manuscript
Any experimental model of infection has limitations. Here, we propose using the described
experimental model to define the mechanisms of endometritis-mediated subfertility.
However, using heifers as the experimental unit limits our understanding of the reproductive
potential of the individual animal, unlike using mature lactating cows that would normally
have uterine disease. Additionally, the use of heifers revealed experimental limitations
because of body size and ability to perform the manipulations in 12- to 13-mo-old animals,
indicated by the consistent day effect of some hematological parameters. Experimentation
Author Manuscript
induced infection will be critical to establish the validity of the model to study endometritis-
Author Manuscript
CONCLUSIONS
We have successfully created a model of experimentally induced clinical endometritis in
virgin Holstein heifers. This model will allow the investigation into the mechanisms of
endometritis-associated reproductive failure. The use of an experimental model of
endometritis allows investigation into endometritis-mediated sub-fertility independent of
confounding postpartum events common in lactating cows that may influence reproductive
physiology. We used a combination of interventions to facilitate uterine infection, including
disruption of the endometrial epithelial barrier, supplementation of exogenous P4, and
infusion of uterine pathogenic bacteria. We conclude that our experimental model
recapitulates clinical endometritis symptoms in virgin Holstein heifers.
Author Manuscript
ACKNOWLEDGMENTS
The authors thank Todd Pritchard, Miguel To-rrado, and the University of Florida Dairy Research Unit staff for
their assistance. Research reported in this publication was supported by the Eunice Kennedy Shriver National
Institute of Child Health & Human Development of the National Institutes of Health (Bethesda, MD) under Award
Number R01HD084316. The content is solely the responsibility of the authors and does not necessarily represent
the official views of the National Institutes of Health.
REFERENCES
Amos MR, Healey GD, Goldstone RJ, Mahan SM, Duvel A, Schuberth HJ, Sandra O, Zieger P,
Dieuzy-Labaye I, Smith DG, and Sheldon IM. 2014 Differential endometrial cell sensitivity to a
cholesterol-dependent cytolysin links Trueperella pyogenes to uterine disease in cattle. Biol. Reprod
90:54. [PubMed: 24478394]
Author Manuscript
Ayliffe TR, and Noakes DE. 1982 Effects of exogenous oestrogen and experimentally induced
endometritis on absorption of sodium benzylpenicillin from the cow’s uterus. Vet. Rec 110:96–98.
[PubMed: 7186696]
Bicalho ML, Machado VS, Oikonomou G, Gilbert RO, and Bicalho RC. 2012 Association between
virulence factors of Escherichia coli, Fusobacterium necrophorum, and Arcanobacterium pyogenes
and uterine diseases of dairy cows. Vet. Microbiol 157:125–131. [PubMed: 22186615]
Bromfield JJ, and Sheldon IM. 2011 Lipopolysaccharide initiates inflammation in bovine granulosa
cells via the TLR4 pathway and perturbs oocyte meiotic progression in vitro. Endocrinology
152:5029–5040. [PubMed: 21990308]
Bromfield JJ, and Sheldon IM. 2013 Lipopolysaccharide reduces the primordial follicle pool in the
bovine ovarian cortex ex vivo and in the murine ovary in vivo. Biol. Reprod 88:98. [PubMed:
23515670]
The Bovine Genome Sequencing and Analysis Consortium, Elsik CG, Tellam RL, and Worley. KC
2009 The genome sequence of taurine cattle: A window to ruminant biology and evolution. Science
324:522–528. [PubMed: 19390049]
Author Manuscript
Chagas LM, Bass JJ, Blache D, Burke CR, Kay JK, Lindsay DR, Lucy MC, Martin GB, Meier S,
Rhodes FM, Roche JR, Thatcher WW, and Webb R. 2007 Invited review: New perspectives on the
roles of nutrition and metabolic priorities in the subfertility of high-producing dairy cows. J. Dairy
Sci 90:4022–4032. [PubMed: 17699018]
Del Vecchio RP, Matsas DJ, Inzana TJ, Sponenberg DP, and Lewis GS. 1992 Effect of intrauterine
bacterial infusions and subsequent endometritis on prostaglandin F2 alpha metabolite concentrations
in postpartum beef cows. J. Anim. Sci 70:3158–3162. [PubMed: 1429292]
Dohmen MJ, Joop K, Sturk A, Bols PE, and Lohuis JA. 2000 Relationship between intra-uterine
bacterial contamination, endotoxin levels and the development of endometritis in postpartum cows
Author Manuscript
LeBlanc SJ 2012 Interactions of metabolism, inflammation, and reproductive tract health in the
postpartum period in dairy cattle. Reprod. Domest. Anim 47(Suppl 5):18–30.
LeBlanc SJ, Duffield TF, Leslie KE, Bateman KG, Keefe GP, Walton JS, and Johnson WH. 2002
Defining and diagnosing postpartum clinical endometritis and its impact on reproductive
performance in dairy cows. J. Dairy Sci 85:2223–2236. [PubMed: 12362455]
Lewis GS 1997 Uterine health and disorders. J. Dairy Sci 80:984–994. [PubMed: 9178140]
Lewis GS 2003 Role of ovarian progesterone and potential role of prostaglandin F2alpha and
prostaglandin E2 in modulating the uterine response to infectious bacteria in postpartum ewes. J.
Anim. Sci 81:285–293. [PubMed: 12597400]
Lima FS, Ribeiro ES, Bisinotto RS, Greco LF, Martinez N, Amstalden M, Thatcher WW, and Santos
JE. 2013 Hormonal manipulations in the 5-day timed artificial insemination protocol to optimize
estrous cycle synchrony and fertility in dairy heifers. J. Dairy Sci 96:7054–7065. [PubMed:
24011941]
Opsomer G, Grohn YT, Hertl J, Coryn M, Deluyker H, and de Kruif A. 2000 Risk factors for post
Author Manuscript
partum ovarian dysfunction in high producing dairy cows in Belgium: A field study.
Theriogenology 53:841–857. [PubMed: 10730974]
Potter TJ, Guitian J, Fishwick J, Gordon PJ, and Sheldon IM. 2010 Risk factors for clinical
endometritis in postpartum dairy cattle. Theriogenology 74:127–134. [PubMed: 20207407]
Regassa F, Sheldon M, and Noakes DE. 2002 Effect of experimentally induced metritis on uterine
involution, acute phase protein response and PGFM secretion in the postpartum ewe. Vet. Rec
150:605–607. [PubMed: 12036244]
Ribeiro ES, Gomes G, Greco LF, Cerri RLA, Vieira-Neto A, Monteiro PLJ, Jr., Lima FS, Bisinotto RS,
Thatcher WW, and Santos. JEP 2016 Carryover effect of postpartum inflammatory diseases on
developmental biology and fertility in lactating dairy cows. J. Dairy Sci 99:2201–2220. [PubMed:
26723113]
Author Manuscript
Ribeiro ES, Lima FS, Greco LF, Bisinotto RS, Monteiro AP, Favoreto M, Ayres H, Marsola RS,
Martinez N, Thatcher WW, and Santos JE. 2013 Prevalence of periparturient diseases and effects
on fertility of seasonally calving grazing dairy cows supplemented with concentrates. J. Dairy Sci
96:5682–5697. [PubMed: 23831093]
Rowson LE, Lamming GE, and Fry RM. 1953 Influence of ovarian hormones on uterine infection.
Nature 171:749–750. [PubMed: 13054704]
Seals RC, Wulster-Radcliffe MC, and Lewis GS. 2002 Modulation of the uterine response to infectious
bacteria in postpartum ewes. Am. J. Reprod. Immunol 47:57–63. [PubMed: 11883750]
Seok J, Warren HS, Cuenca AG, Mindrinos MN, Baker HV, Xu W, Richards DR, McDonald-Smith
GP, Gao H, Hennessy L, Finnerty CC, Lopez CM, Honari S, Moore EE, Minei JP, Cuschieri J,
Bankey PE, Johnson JL, Sperry J, Nathens AB, Billiar TR, West MA, Jeschke MG, Klein MB,
Gamelli RL, Gibran NS, Brownstein BH, Miller-Graziano C, Calvano SE, Mason PH, Cobb JP,
Rahme LG, Lowry SF, Maier RV, Moldawer LL, Herndon DN, Davis RW, Xiao W, and Tompkins
RG. Inflammation and Host Response to Injury, and Large Scale Collaborative Research Program.
Author Manuscript
2013 Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc.
Natl. Acad. Sci. USA 110:3507–3512. [PubMed: 23401516]
Sheldon IM, Cronin J, Goetze L, Donofrio G, and Schuberth HJ. 2009 Defining postpartum uterine
disease and the mechanisms of infection and immunity in the female reproductive tract in cattle.
Biol. Reprod 81:1025–1032. [PubMed: 19439727]
Sheldon IM, Lewis GS, LeBlanc S, and Gilbert RO. 2006 Defining postpartum uterine disease in
cattle. Theriogenology 65:1516–1530. [PubMed: 16226305]
Sheldon IM, Noakes DE, Rycroft A, and Dobson H. 2001 Acute phase protein responses to uterine
bacterial contamination in cattle after calving. Vet. Rec 148:172–175. [PubMed: 11258722]
Sheldon IM, Noakes DE, Rycroft AN, Pfeiffer DU, and Dobson H. 2002 Influence of uterine bacterial
contamination after parturition on ovarian dominant follicle selection and follicle growth and
function in cattle. Reproduction 123:837–845. [PubMed: 12052238]
Sheldon IM, and Roberts MH. 2010 Toll-like receptor 4 mediates the response of epithelial and
stromal cells to lipopolysaccharide in the endometrium. PLoS One 5:e12906. [PubMed:
20877575]
Author Manuscript
Sheldon IM, Rycroft AN, Dogan B, Craven M, Bromfield JJ, Chandler A, Roberts MH, Price SB,
Gilbert RO, and Simpson KW. 2010 Specific strains of Escherichia coli are pathogenic for the
endometrium of cattle and cause pelvic inflammatory disease in cattle and mice. PLoS One
5:e9192. [PubMed: 20169203]
Turner ML, Cronin JG, Healey GD, and Sheldon IM. 2014 Epithelial and stromal cells of bovine
endometrium have roles in innate immunity and initiate inflammatory responses to bacterial
lipopeptides in vitro via Toll-like receptors TLR2, TLR1, and TLR6. Endocrinology 155:1453–
1465. [PubMed: 24437488]
Wira CR, Rodriguez-Garcia M, and Patel MV. 2015 The role of sex hormones in immune protection of
the female reproductive tract. Nat. Rev. Immunol 15:217–230. [PubMed: 25743222]
Author Manuscript
Figure 1.
Requirements for establishment of experimental uterine infection. (A) Timeline of
experimental procedures employed during the experimental period. Gonadotropin-releasing
hormone and PGF2α were used to synchronize estrous cycles in 9 virgin Holstein heifers
before intrauterine infusion of treatments. On d 0, intrauterine infusion of either vehicle or
live bacteria was performed. Vehicle infusion consisted of 30 mL of sterile Luria-Bertani
Author Manuscript
broth. Bacteria infusion consisted of 10 mL of Escherichia coli MS 499 (4.64 × 107 cfu/mL),
10 mL of Trueperella pyogenes MS249 (3.38 × 107 cfu/mL), and 10 mL of sterile Luria-
Bertani broth. Progesterone (P4) was administered at 200 mg/d i.m. Days relative to
treatment for evaluation of plasma haptoglobin (hpt), P4 (P4), and hematology (hem) are
indicated in italics. (B) The tool used to enable scarification of the endometrium.
Author Manuscript
Author Manuscript
Figure 2.
Clinical observations of induced uterine disease. (A) Vaginal mucus was visually confirmed
in heifers receiving bacterial infusion. (B) Metricheck (Simcro, Hamilton, New Zealand)
tool containing vaginal mucus of a bacteria-infused heifer. (C) Examples of vaginal mucus
samples collected from bacteria-infused heifers using the Metricheck tool. (D and E)
Author Manuscript
Figure 3.
Vaginal mucus grade following intrauterine infusion of bacteria. Vaginal mucus was
collected using a Metricheck (Metricheck, Simcro, Hamilton, New Zealand) tool and graded
according to Sheldon et al. (2009). Vaginal mucus was graded from 0 to 3 and each heifer is
Author Manuscript
represented by a single circle. Control heifers are represented by open circles (A, ○), and
bacteria-infused heifers are represented by filled circles (B, ●). The vertical dotted line
denotes the day of treatment; solid horizontal lines indicate the median vaginal mucus score
for the day of observation. Data were analyzed using the GLIMMIX procedure following a
Poisson distribution to determine the effect of treatment (Trt).
Figure 4.
Effect of treatment on vaginal mucus 16S rRNA and circulating concentrations of
haptoglobin and progesterone in plasma. (A) Total 16S rRNA quantification from vaginal
mucus on d −5, −1, 1, and 5 relative to treatment in either control (open bars) or bacteria-
infused (solid bars) heifers. Total 16S rRNA was normalized to the weight of vaginal mucus
processed for nucleic acid extraction (ng of rRNA per mg of mucus). Different letters denote
Author Manuscript
differences within the bacteria-infused group; * denotes difference between treatment groups
on a given day (P < 0.05). (B) Haptoglobin plasma concentration (ng/mL) was measured in
control (○) and bacteria-infused (●) heifers on d 0, 7, and 13 relative to treatment. (C)
Progesterone plasma concentration (ng/mL) was measured in control (○) and bacteria-
infused (●) heifers on d −2, 1, 4, 11, and 15 relative to treatment. Progesterone (P4) denotes
the period of exogenous administration of 200 mg/d of P4. All data are presented as LSM ±
SEM.
Table 1.
Treatment 3
P-value
Piersanti et al.
Treatment 3
P-value
1 50.12 58.35
3 50.98 51.23
7 60.80 52.70
LYM (K/μL) −1 5.20 6.25 0.43 0.29 0.59 0.51
1 6.14 7.35
3 5.33 6.64
7 6.89 6.07
MON (%) −1 17.44 16.95 1.88 0.52 0.27 0.37
1 18.32 14.93
3 18.00 26.60
7 14.32 17.18
MON (K/μL) −1 2.13 1.95 0.20 0.84 0.32 0.47
1 2.28 2.18
3 1.83 1.84
7 1.59 2.11
EOS (%) −1 7.42 6.30 1.00 0.86 0.13 0.27
1 6.68 5.50
3 6.80 9.18